Literature DB >> 17285195

Update on liver transplantation: indications, organ allocation, and long-term care.

Patricia M Lopez1, Paul Martin.   

Abstract

Liver transplantation (LT) is definitive treatment for patients with acute liver failure and end- stage liver disease and in a subset of primary hepatic malignancies. For patients who successfully undergo LT, the probability of long-term graft and recipient survival is generally excellent, with a high likelihood of return to a relatively normal lifestyle. This article will review current indications, contraindications and postoperative care in LT. With the number of potential recipients far exceeding the number of deceased donor organs, new strategies are being explored to increase access to LT, including: splitting cadaveric donor livers, the use of living donors, and the adoption of the Model for End-Stage Liver Disease (MELD) scoring system, which is based on a mathematical formula to stratify patients in greatest need of transplantation. The allocation of deceased donor organs will, however, remain a contentious issue unless the donor pool is greatly expanded.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17285195

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  12 in total

1.  Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.

Authors:  Memy H Hassan; Mohamed M Ghobara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-31       Impact factor: 3.000

2.  The current economic burden of cirrhosis.

Authors:  Guy W Neff; Christopher W Duncan; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  Resetting the transcription factor network reverses terminal chronic hepatic failure.

Authors:  Taichiro Nishikawa; Aaron Bell; Jenna M Brooks; Kentaro Setoyama; Marta Melis; Bing Han; Ken Fukumitsu; Kan Handa; Jianmin Tian; Klaus H Kaestner; Yoram Vodovotz; Joseph Locker; Alejandro Soto-Gutierrez; Ira J Fox
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

4.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

5.  Liver transplantation.

Authors:  Deok-Bog Moon; Sung-Gyu Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

6.  New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.

Authors:  Luiz Anastácio Alves; André Bonavita; Kátia Quaresma; Elenilde Torres; Paulo Anastácio Furtado Pacheco; Vinícius Cotta-de-Almeida; Roberto Magalhães Saraiva
Journal:  Cell Med       Date:  2010-07-01

7.  Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.

Authors:  Lindsay M Morton; Ola Landgren; Nilanjan Chatterjee; David Castenson; Ruth Parsons; Robert N Hoover; Eric A Engels
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

Review 8.  [Model for end-stage liver disease. New basis of allocation for liver transplantations].

Authors:  G E Jung; J Encke; J Schmidt; A Rahmel
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

Review 9.  Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure.

Authors:  Liana Monteiro da Fonseca Cardoso; Lucio Filgueiras Pacheco Moreira; Marcelo Alves Pinto; Andrea Henriques-Pons; Luiz Anastácio Alves
Journal:  Can J Gastroenterol Hepatol       Date:  2018-07-02

10.  Liver-enriched transcription factor expression relates to chronic hepatic failure in humans.

Authors:  Jorge Guzman-Lepe; Eduardo Cervantes-Alvarez; Alexandra Collin de l'Hortet; Yang Wang; Wendy M Mars; Yoshinao Oda; Yuki Bekki; Masahiro Shimokawa; Huanlin Wang; Tomoharu Yoshizumi; Yoshihiko Maehara; Aaron Bell; Ira J Fox; Kazuki Takeishi; Alejandro Soto-Gutierrez
Journal:  Hepatol Commun       Date:  2018-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.